Physician

Steve Hoonsang Kim, M.D.

According to 2025 Medicare claims, Steve Kim, M.D. (NPI: 1457408064) practices ophthalmology in the Mount Vernon-Anacortes, WA market, with the plurality of this provider's patient population coming from Skagit, WA. This provider's primary affiliated billing organization is PACIFIC NORTHWEST RETINA PLLC (NPI: 1558940387; TIN: 853763379) and primary practice location at 98233-3105.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 702 traditional Medicare patients, billed 47,544 HCPCS/CPT codes, and received $3,952,990 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 373 prescription claims across 128 beneficiaries totaling $30,415 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 13 records totaling $273. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $726,436 to $3,952,990. Similarly, Part D prescription costs have moved sharply higher in recent years, from $45,640 to $30,415. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $726,436 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,145,681 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,369,414 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,737,587 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,299,930 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,190,520 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,213,228 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,174,111 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,485,081 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,952,990 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156019,650$726,436
201666910,480$2,145,681
201775111,918$2,369,414
201873013,441$2,737,587
201985114,899$3,299,930
202074812,546$3,190,520
202172912,979$3,213,228
202274413,499$3,174,111
202375624,718$3,485,081
202470247,544$3,952,990

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2015 Drug cost: $45,640 (USD; Tot_Drug_Cst)2016 Drug cost: $15,291 (USD; Tot_Drug_Cst)2017 Drug cost: $14,241 (USD; Tot_Drug_Cst)2018 Drug cost: $19,208 (USD; Tot_Drug_Cst)2019 Drug cost: $18,619 (USD; Tot_Drug_Cst)2020 Drug cost: $21,386 (USD; Tot_Drug_Cst)2021 Drug cost: $30,505 (USD; Tot_Drug_Cst)2022 Drug cost: $36,869 (USD; Tot_Drug_Cst)2023 Drug cost: $44,144 (USD; Tot_Drug_Cst)2024 Drug cost: $30,415 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201551144$45,640
201696228$15,291
2017101260$14,241
2018120292$19,208
2019146375$18,619
2020117319$21,386
2021132345$30,505
2022139431$36,869
2023147440$44,144
2024128373$30,415

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2291,946$656
67028Injection of drug into eye3861,882$97
92014Established patient complete exam of visual system434531$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more420764$66
92134Imaging of retina6792,533$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1193,362$3,970
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat513,745$1,089
Ketorolac TromethamineKetorolac Tromethamine26882$991
OfloxacinOfloxacin591,432$845
Brimonidine TartrateBrimonidine Tartrate301,379$333

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.13$273Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Steve Hoonsang Kim, M.D.?

Tedicare shows public-source Medicare data for Steve Hoonsang Kim, M.D. (NPI 1457408064), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steve Hoonsang Kim, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steve Hoonsang Kim, M.D.?

Steve Hoonsang Kim, M.D. is linked to PACIFIC NORTHWEST RETINA PLLC (billing NPI 1558940387) in the available physician profile data.

Does Steve Hoonsang Kim, M.D. have Open Payments data?

Steve Hoonsang Kim, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.